Trial Profile
Sustaining Remission of Psychotic Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2023
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Sertraline
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms STOP-PD; STOP-PD-II
- 08 Jun 2023 Results(n=80) published in the Journal of Affective Disorders
- 26 Feb 2020 Results (n=88) published in the JAMA Psychiatry
- 20 Aug 2019 Primary endpoint (Number of Subjects at Risk of Relapse During the Randomized Phase.) has been met, according to the results published in the JAMA: the Journal of the American Medical Association